Tokyo Tape
Sign in
← Tohoku Chemical

Quarterly report · Q2

7446.TEDINET S100QQHV
Period2022-10-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥18.4bn2022-10-01 → 2023-03-31Cons.Net sales
Revenue¥37.3bn2021-10-01 → 2022-09-30Cons.Net sales (5-year summary)
Revenue¥19.2bn2021-10-01 → 2022-03-31Cons.Net sales
Operating income¥532m2022-10-01 → 2023-03-31Cons.Operating income
Operating income¥551m2021-10-01 → 2022-03-31Cons.Operating income
Ordinary income¥552m2022-10-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥1.0bn2021-10-01 → 2022-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥572m2021-10-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥552m2022-10-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥546m2021-10-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥367m2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥658m2021-10-01 → 2022-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥372m2021-10-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥373m2022-10-01 → 2023-03-31Cons.Profit loss
Net income¥388m2021-10-01 → 2022-03-31Cons.Profit loss
Total assets¥17.8bnat 2023-03-31Cons.Assets
Total assets¥17.5bnat 2022-09-30Cons.Assets
Total assets¥16.7bnat 2022-03-31Cons.Total assets (5-year summary)
Total liabilities¥10.8bnat 2023-03-31Cons.Liabilities
Total liabilities¥10.8bnat 2022-09-30Cons.Liabilities
Net assets / equity¥7.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥6.7bnat 2022-09-30Cons.Net assets
Net assets / equity¥6.4bnat 2022-03-31Cons.Net assets (5-year summary)
Cash and deposits¥1.3bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥1.4bnat 2022-09-30Cons.Cash and deposits
Cash & equivalents¥1.1bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥660mat 2021-09-30dCons.Cash and cash equivalents
Operating cash flow¥185m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥886m2021-10-01 → 2022-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥984m2021-10-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥288m2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥92m2021-10-01 → 2022-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥83m2021-10-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥46m2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥186m2021-10-01 → 2022-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥102m2021-10-01 → 2022-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥407.212022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥204.92023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥728.762021-10-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥411.922021-10-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥248.52022-01-01 → 2022-03-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio38.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio37.7%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio38.0%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Otherother segmentsrevenue2022-10-01 → 2023-03-31¥101m
Otherother segmentsrevenue external2022-10-01 → 2023-03-31¥101m
jpcrp040300-q2r_E02810-000Foodreportable segmentrevenue2022-10-01 → 2023-03-31¥1.7bn
jpcrp040300-q2r_E02810-000Foodreportable segmentrevenue external2022-10-01 → 2023-03-31¥1.7bn
jpcrp040300-q2r_E02810-000Pharmaceutical Productsreportable segmentrevenue2022-10-01 → 2023-03-31¥9.2bn
jpcrp040300-q2r_E02810-000Pharmaceutical Productsreportable segmentrevenue external2022-10-01 → 2023-03-31¥9.2bn
jpcrp040300-q2r_E02810-000Reagent For Clinical Testreportable segmentrevenue2022-10-01 → 2023-03-31¥7.5bn
jpcrp040300-q2r_E02810-000Reagent For Clinical Testreportable segmentrevenue external2022-10-01 → 2023-03-31¥7.5bn
—segment totalrevenue2022-10-01 → 2023-03-31¥18.4bn
—segment totalrevenue external2022-10-01 → 2023-03-31¥18.4bn
Otherother segmentsrevenue2021-10-01 → 2022-03-31¥125m
Otherother segmentsrevenue external2021-10-01 → 2022-03-31¥125m
jpcrp040300-q2r_E02810-000Foodreportable segmentrevenue2021-10-01 → 2022-03-31¥1.6bn
jpcrp040300-q2r_E02810-000Foodreportable segmentrevenue external2021-10-01 → 2022-03-31¥1.6bn
jpcrp040300-q2r_E02810-000Pharmaceutical Productsreportable segmentrevenue2021-10-01 → 2022-03-31¥9.7bn
jpcrp040300-q2r_E02810-000Pharmaceutical Productsreportable segmentrevenue external2021-10-01 → 2022-03-31¥9.7bn
jpcrp040300-q2r_E02810-000Reagent For Clinical Testreportable segmentrevenue2021-10-01 → 2022-03-31¥7.8bn
jpcrp040300-q2r_E02810-000Reagent For Clinical Testreportable segmentrevenue external2021-10-01 → 2022-03-31¥7.8bn
—segment totalrevenue2021-10-01 → 2022-03-31¥19.2bn
—segment totalrevenue external2021-10-01 → 2022-03-31¥19.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 520
ItemContextValueUnit
Xbrl amendment flagFilingDateInstantfalse
Business results of group (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus
Management analysis of financial position operating results and cash flows (text)FilingDateInstantText · Plus
Critical contracts for operation (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所スタンダード市場
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)単元株式数は100株であります。
Details of employee share option program (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)東北化学薬品取引先持株会
Address major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)青森県弘前市大字神田１－３－１
Name major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)東北化学薬品従業員持株会
Address major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)青森県弘前市大字神田１－３－１
Name major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)東京中小企業投資育成㈱
Address major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)東京都渋谷区渋谷３－29－22
Name major shareholdersCurrentQuarterInstant_No4MajorShareholdersMember
Original text (Japanese)東　康夫
Address major shareholdersCurrentQuarterInstant_No4MajorShareholdersMember
Original text (Japanese)青森県弘前市
Name major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)㈱青森銀行
Address major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)青森県青森市橋本１－９－30
Name major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)㈱みちのく銀行
Address major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)青森県青森市勝田１－３－１
Name major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)東　康之
Address major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)青森県弘前市
Name major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)日本曹達㈱
Address major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)東京都千代田区大手町２－２－１
Name major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)シスメックス㈱
Address major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)兵庫県神戸市中央区脇浜海岸通１－５－１
Name major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)東ソー・ニッケミ㈱
Address major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)東京都港区芝２－５－10
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember－
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember
Original text (Japanese)１単元（100株）未満の株式
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)東北化学薬品㈱
Address of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)青森県弘前市大字神田１-３-１
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which consolidated financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Quarterly consolidated balance sheet (text)CurrentYTDDurationText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-09-30pass
balance sheet identityconsolidated 2023-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2021-10-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-10-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass